CDC Updates RSV Vaccination Recommendation for Adults
WEBJun 26, 2024 — Today, CDC updated its recommendation for the use of Respiratory Syncytial Virus (RSV) vaccines in people ages 60 and older. For this upcoming respiratory virus season, CDC recommends: Everyone ages 75 and older receive the RSV vaccine.
Should You Get the New RSV Vaccine? > News - Yale Medicine
WEBSep 25, 2023 — Respiratory syncytial virus (RSV) causes mild cold symptoms in most people but can lead to hospitalization and even death in older people and babies. But now, there are new immunizations aimed at older people, babies, and pregnant women who want to protect their newborns.
The new RSV vaccines for older adults - Mayo Clinic Press
WEBSep 19, 2023 — In May 2023, pharmaceutical companies GSK and Pfizer received approval from the U.S. Food and Drug Administration (FDA) for their RSV vaccines within weeks of each other. Both vaccines are currently available. Here’s what you need to know about RSV and the two new vaccines designed to protect against it.
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
WEBMay 4, 2023 — Today, the U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy is approved for the prevention of...
New RSV vaccine guidelines: Adults 75+ urged to vaccinate - Yahoo
WEB1 day ago — CDC panel recommends RSV vaccines for seniors According to the CDC , 100,000 older adults a year end up in the hospital, and about 10,000 older adults die from RSV every year.
FDA approves first vaccine for RSV, a moment six decades in the ... - CNN
WEBMay 3, 2023 — The US Food and Drug Administration approved the first vaccine against respiratory syncytial virus, known as RSV, and vaccines are in the works.
Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
WEBMay 31, 2024 — mRESVIA (Respiratory Syncytial Virus Vaccine) is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in adults 60 years of age and older.
FDA approves Moderna’s mRNA RSV vaccine for older adults
WEBMay 31, 2024 — The US Food and Drug Administration has approved another vaccine that can help protect older people from respiratory syncytial virus, known as RSV. The shot, made by Moderna and sold under the name...
CDC recommends RSV shots, enabling vaccinations to begin ... - NBC News
WEBJun 21, 2023 — An independent advisory committee to the FDA voted last month to recommend Pfizer’s maternal RSV vaccine, which is given to pregnant mothers to protect their infants from RSV. The vaccine...
FDA advisers recommend world's first RSV vaccines, from ... - NBC News
WEBMar 1, 2023 — An FDA advisory committee has recommended that the agency approve two RSV vaccines for older people, one from Pfizer and another from GSK.